跳至主要内容
临床试验/CTRI/2023/03/050182
CTRI/2023/03/050182尚未招募2 期

A COMPARATIVE STUDY TO EVALUATE THE EFFECT OF AMRITA BHALLATAKA WITH VIRECHANA VS KOSHTHASHODHANA IN THE MANAGEMENT OF AMAVATA ( RHEUMATOID ARTHRITIS), A RANDOMISED CLINICAL STUDY

ALL INDIA INSTITUE OF AYURVEDA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients having the clinical manifestation of Amavata (RA) according to Ayurvedic classics
  • - Sandhishool (pain), shoth (swelling), sparshasahata (tenderness) and stabdhata
  • (stiffness),Vrishichikadansavata vedana(pain like scorpion sting), Agnimandya (poor
  • digestion) , Aruchi(anorexia), Gaurav(Feeling of heaviness of body),Utsaha Hani(lack of
  • interest),Mukha vairasya(Perverted taste).
  • 2. Diagnosed cases of amavata (RA)
  • 3. Patients willing to participate in the research study.

排除标准

  • 1) Patients with other systemic complications of RA like RHD, Rheumatic fever, pleural â??
  • pericardial disease.
  • 2) Patients with poorly controlled Hypertension ( >160/100 mm of Hg)
  • 3) Patients with Diabetes Mellitus {B.S. (F) > 126 mg% and / or B.S. (2 hr. PP) >200 mg%
  • OR HbA1c > 6.5%}
  • 4) Patients diagnosed with other arthritis like gouty arthritis, tuberculous arthritis, etc.
  • 5) Patients who are unable to walk without support and / or confined to wheel chair.
  • 6) H/o hypersensitivity to any of the trial drugs or their ingredients.
  • 7) Patients on prolonged ( > 6 weeks) medication with antidepressants, anticholinergic, etc. or
  • any other drugs that may have an influence on the outcome of the study.
  • 8) Pregnant / lactating woman.
  • 9) Patients who have completed participation in any other clinical trial during the past 6
  • 10) Patients allergic to any content of the drug.

研究者

发起方
ALL INDIA INSTITUE OF AYURVEDA

相似试验